Well...Took a little off the table from $27. Up 30% in 2 weeks has built in a good amount of any buyout premium.
The rest gets put away and waits...Good luck.
ETN is much cheaper and has a much larger dividend.
Still think AME might get bought but looks like it would happen at a a price that would be around this level or even lower down the road.
Stock jumped from $6.85 to $7.98 on March 2nd and since that time has traded roughly 100 million shares and done absolutely nothing despite positive news and a biotech bounce.
Shorts are not covering either. It just churns day after day after day with a seemingly endless supply of shares to keep it right around $8.
No follow-up news to positive EU opinion is not helping either. Does management even look at the share price ever?
It should breakout one day but it seems this one has missed a huge opportunity to be a real big winner and I think upper management is clearly to blame.
Earnings will be another huge miss as these guys are wasting millions of dollars every qtr.
Management is a joke and the street knows it.
A year ago the short interest was only 5 million shares.
CEO compensation package totaled $4.7 million in 2015 UP from $2.7 million in 2014.
HUGE warning sign.
You must be joking.
CEO is worthless to the success of this company and is responsible for one of the largest short positions in the entire sector and a stock that is trading at 50% of it's IPO price despite the positive drug developments. Unfortunately, his "story" makes him a lifer no matter how poorly he performs or how low the stock price trades at.
There is NOTHING going on behind the scenes with these guys...Nothing.